Wall Street Analysts Predict a 29.1% Upside in GoodRx Holdings, Inc. (GDRX): Here's What You Should KnowZacks Investment Research • 03/15/24
Can GoodRx Holdings, Inc. (GDRX) Run Higher on Rising Earnings Estimates?Zacks Investment Research • 03/04/24
GoodRx Holdings, Inc. (GDRX) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 03/04/24
GoodRx Holdings, Inc. (GDRX) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 03/01/24
Countdown to GoodRx Holdings, Inc. (GDRX) Q4 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 02/26/24
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference CallBusiness Wire • 02/01/24
How Much Upside is Left in GoodRx Holdings, Inc. (GDRX)? Wall Street Analysts Think 27.83%Zacks Investment Research • 02/01/24
What Makes GoodRx Holdings, Inc. (GDRX) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 01/16/24
Earnings Estimates Rising for GoodRx Holdings, Inc. (GDRX): Will It Gain?Zacks Investment Research • 01/16/24
After Golden Cross, GoodRx Holdings, Inc. (GDRX)'s Technical Outlook is BrightZacks Investment Research • 01/16/24
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription SavingsBusiness Wire • 01/11/24
GoodRx Holdings, Inc. (GDRX) Surges 13.3%: Is This an Indication of Further Gains?Zacks Investment Research • 01/11/24
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024Business Wire • 01/10/24